1)NSCLCⅢ期NSCLC
1.Efficacy of Yan-shu injection combined with concurrent chemoradiotherapy for 45 unresectable stage Ⅲ NSCLC patients;岩舒注射液联合放化疗治疗不可手术Ⅲ期NSCLC 45例临床观察
英文短句/例句
1.Molecular Prognosis and Predictions of Response to Adjuvant Chemotherapy in Stage Ⅰ-Ⅲ Resected Patients with Non-Small Cell Lung CancerⅠ-Ⅲ期NSCLC术后辅助化疗疗效的分子预测及预后研究
2.Vascular Endothelial Growth Factor Expression in Stage I_A Non-Small Cell Lung Cancer and Clinical Significance;VEGF在I_A期NSCLC中的表达和临床意义
3.Influence of age and comorbidity on survival of patients with advanced non-small-cell lung cancer两种因素对晚期NSCLC患者预后的影响
4.Effect of Irinotecan Combined with Radiotherapy in Patients with Advanced Non-small Cell Lung Cancer伊立替康联合放疗治疗晚期NSCLC的疗效
5.Clinical Experience of Treating Senile Advanced Non-small Cell Lung Cancer by Erlotinib厄洛替尼治疗老年晚期NSCLC的临床观察
6.Clinical Significance of Tumor Markers in Patients with Advanced Non-small Cell Lung Cancer;肿瘤标志物在晚期NSCLC诊治中的临床意义和价值
7.The Expression of MTA1 Protein in Stage Ⅰ NSCLC and Its Effect on the Relapse, Metastasis and PrognosisMTA1蛋白表达与Ⅰ期NSCLC复发转移及预后关系研究
8.Observational study on the effects of treating advanced NSCLC usingTP chemotherapy and microwave thermotherapy微波热疗联合化疗治疗晚期NSCLC疗效观察
9.A Meta-analysis of Platinum Plus Taxanes Regimen on Treating Advanced Non-small Cell Lung Cancer铂类联合紫杉类治疗进展期NSCLC的meta分析
10.Combination of Shenmei injection and GP chemotherapy for treatmen of advanced non-small cell lung cancerGP方案联合参麦注射液治疗晚期NSCLC临床观察
11.Expression and Significance of Survivin and Bcl-2 in Stage I Non-small Lung CancerSurvivin、Bcl-2在I期NSCLC中的表达及其临床意义
12.Disease control rate and survival in advanced non-small cell lung cancer after first-line chemotherapy晚期NSCLC一线化疗疾病控制与生存关系的分析
13.The Clinical Research of Acupuncture Matches the Combination of TCM and Chemotherapy of Ⅲb、Ⅳ NONSmall-Cell Lung Cancer;针刺配合中药辨证治疗加化疗治疗Ⅲb、Ⅳ期NSCLC近期疗效观察
14.The Study of Feitai Capsule on the Impact of Dendritic Cell Function during the Chemotherapy of Stage Ⅳ NSCLC肺泰胶囊对Ⅳ期NSCLC化疗期间树突状细胞功能影响的研究
15.Rh-endostatin in Combination with Chemotherapy in Patients with Advanced Non-small Cell Lung Cancer重组人内皮抑素联合化疗治疗晚期NSCLC近期疗效观察
16.Analysis of short-term effects using accelerated-hypofractiovated three dimensional conformal radiotherapy for late-course NSCLC三维适形后程逐步递量加速放疗局部晚期NSCLC的近期疗效观察
17.Significance of Serum VEGF in Lung Cancer and Angiogenic Inhibitors in the Treatment of Advanced Non-Small Cell Lung Cancer;VEGF在肺癌中的临床意义及抗血管生成药物二线治疗晚期NSCLC
18.Clinical Significance of Immunohistochemically Detecting Positve Expression of Cytokeratin in Lymph Nodes of Patients with Stage Ⅰ Non-Small-Cell Lung Cancer;CK免疫组化染色在Ⅰ期NSCLC患者淋巴结中的表达及其临床意义
相关短句/例句
advanced NSCLC晚期NSCLC
1.Methods:Eight possible influencing factors were analyzed,data of the 76 post-chemotherapeutic acquired pneumonia of advanced NSCLC from June 2003 to June 2006 was conducted.方法:选择8个可能对化疗后获得性肺炎产生影响的研究因素,进行Logistic回归分析,对我院2003年6月～2006年6月期间收治的76例晚期NSCLC化疗后获得性肺炎患者进行研究。
3)Ⅲa stage NSCLCⅢa期NSCLC
4)phase ⅢⅢ期
1.Nemifitide is a synthetic peptide in the phase Ⅲ clinical trials.奈米非肽是一种正在进行Ⅲ期临床试验的人工合成肽类抗抑郁药。
5)125I implantation125I Ⅲ b期
6)stage Ⅱ and ⅢⅡ、Ⅲ期
1.Clinical and pathological character analysis of colorectal cancer instage Ⅱ and Ⅲ;Ⅱ、Ⅲ期结直肠癌临床病理特征分析
延伸阅读
欧洲式期权、美国式期权与亚洲式期权欧洲式期权、美国式期权与亚洲式期权 【欧洲式期权、美国式期权与亚洲式期权】期权合约所规定的权利有一定的时效期，过了失效日后，权利即行作废。一些期权规定权利仅能在有效期的最后一天执行，这种期权被称为欧洲式期权(ell功pean叩tions);另一些期权则容许在有效期内任何一天执行，这种期权被称为美国式期权(一~oPtions)。值得指出的是，虽名为欧洲式或美国式期权，但已无任何地理上的意义。由于欧洲式期权的规定过于严格，又出现了一种“改变的欧洲式期权”，它允许期权在一定的时间范围内进行交易。可见，美国式期权为期权购买者提供了更多的选择机会，因此，它的购买者也往往需支付更高的保险费。近年来无论在欧洲或美国，所交易的期权均以美国式为主，欧洲式期权虽仍存在，但其交易量已比不上美国式期权。 在so年代末期，市场上又出现了一种所谓亚洲式期权(asian ontions)，但也无地理上的意义，其差别主要在于履约价值(exe而sev公此)的计算。以买权为例，无论是美国式期权或是欧洲式期权，执行权利所能得到的履约价值均为当时标的物的市价减去履约价格，再乘以合约所定的数量，但亚洲式期权的履约价值则为权利期间内标的物市价的平均(计算至履约日为止)，减去履约价格，再乘以合约所定的数量。
